Bioretec Ltd Unveils Resolutions from 2026 Annual General Meeting: Key Decisions and Future Directions
Bioretec Ltd’s Annual General Meeting 2026 Overview
On May 8, 2026, Bioretec Ltd held its Annual General Meeting (AGM) as a hybrid event, enabling participation both physically and remotely, in accordance with the Finnish Companies Act. This format demonstrates the company's commitment to modernizing shareholder engagement practices while adhering to regulatory requirements.
Financial Statements Approved
One of the key decisions at the AGM was the approval of the financial statements for the fiscal year ending December 31, 2025. The assembly resolved to discharge the current Board of Directors and the Chief Executive Officers from liability concerning the same period, reflecting the board's confidence in their management and oversight.
In a notable financial decision, the AGM acknowledged a substantial loss of EUR 7,873,906.59 for 2025, which will be credited under